Filter

51 - 60 of 811 Results

  • Kaiser Health Policy News Index October 2014: Ebola In U.S. And Africa Top Public Attention To Health News

    Kaiser Health Policy News Index: Special Focus On Ebola

    Feature

    With the Ebola outbreak in West Africa and individual cases in the U.S. and Europe making international headlines, the latest Kaiser Health Policy News Index examines Americans’ attention to the Ebola crisis, awareness of key facts about the disease, and views of the U.S. role in addressing Ebola in Africa and at home.

  • The Public’s Policy Agenda for the 113th Congress: Briefing and Panel Discussion

    Event Date:
    Event

    As the 113th Congress is sworn in, and President Barack Obama begins his second term of office, a comprehensive new Kaiser Family Foundation/Robert Wood Johnson Foundation/Harvard School of Public Health survey queried the public about their priorities for, and views on, a wide range of health and health policy issues. These include issues that will preoccupy federal lawmakers, such as the role of Medicare in the deficit reduction debate, as well as issues currently being…

  • Policy and Political Implications of the Supreme Court Case on the Affordable Care Act

    Event Date:
    Event

    This webcast features a Kaiser Family Foundation briefing held on March 14, 2012, examining the policy and political implications of the pending U.S. Supreme Court case on the Affordable Care Act (ACA). At the briefing, the Foundation released new polling data on the public’s views about the case as well as their more general views about the health reform law. Participants included: Kaiser President and CEO Drew Altman (moderator)Joe Onek, Principal, The Raben Group Sheila…

  • Misinformation About Immigrants in the 2024 Presidential Election

    Poll Finding

    With the 2024 election season underway, a large majority of the public reports hearing false claims about immigrants from candidates or elected officials, and many immigrants say Donald Trump's rhetoric in particular is negatively affecting how they are treated. This poll finding also gauges understanding about U.S. immigrants' eligibility for government benefits programs.

  • KFF Health Tracking Poll September 2024: Harris v. Trump on Key Health Care Issues

    Feature

    Prior to the first fall presidential debate, a growing share of voters see the election as a referendum on abortion access, and Vice President Harris holds a strong advantage over former President Trump on the issue. The economy and inflation remain voters' top issue, and many want to hear the candidates address health care costs.

  • Loneliness and Social Support Networks: Findings from the KFF Survey of Racism, Discrimination and Health 

    Poll Finding

    The issues of loneliness and social isolation gained attention during the COVID-19 pandemic, and continue to be associated with poor mental and physical health conditions. One in six (15%) adults report feeling always or often lonely in the past year, with the highest shares among young adults ages 18-29. There is a strong relationship between feelings of loneliness, local support networks, and physical and mental health and well-being, but Black, Hispanic, and Asian adults are…

  • KFF Health Misinformation Tracking Poll: Health and Election Issues on TikTok

    Poll Finding

    KFF's Health Misinformation Tracking Poll shows that most adults who use the social media app TikTok report seeing health-related information or advice on the app. While fewer than half of users say they trust health information they see on the app, younger, Black and Hispanic users report higher levels of trust.

  • KFF Health Tracking Poll May 2024: The Public’s Use and Views of GLP-1 Drugs

    Feature

    KFF’s latest Health Tracking Poll examines the public’s views and use of an an increasingly popular class of prescription drugs used for weight loss and to treat diabetes or prevent heart attacks or strokes. The poll finds 12% of adults report having taken one of these GLP-1 drugs, which include Ozempic, Webovy and Mounjaro. This includes 6% who say they are currently taking one of the drugs.